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The cysteine sulfhydryl groups of cu2-macroglobulin (cr2M) generated upon thrombin complex formation 
are in contact with the proteinase surface as evidenced by singlet-singlet energy transfer measurements 
from N-(iodoacetylaminoethyl)-5-naphthylamine-l-sulfonic acid-labeled thiol functions of (YZM to 
fluorescein isothiocyanate-labeled thrombin. The thrombin-cr2M binding is normally covalent, but the 
presence of hydroxylamine during the reaction leads to the formation of a non-covalent complex. The 
transfer energy determinations show that the cu2M binding sites of thrombin are quite similar, whatever 
covalent or non-covalent binding occurs. 
crz-Macroglobulin Thrombin 
1. INTRODUCTION 
The cut-macroglobulin (0zM) molecule is com- 
posed of 2 subunits held together by non-covalent 
forces. Each of them contains 2 identical polypep- 
tide chains linked by disulfide bridges. All 4 chains 
contain a reactive site identified as a thioester 
cross-link between a cysteine and a glutamic acid 
residue [l-4]. Binding of proteases, or treatment 
by primary amines, results in the appearance of 4 
thiol groups and as many activated glutamic acid 
residues able to react covalently with amino groups 
[2,5,6]. The interaction of one cv2M molecule with 
2 trypsins corresponds to covalent binding of 1.3 
molecule, 2.2 + 0.1 of the activated Glx residues 
being engaged in this linkage [7]. 
In [8], using singlet-singlet energy transfer 
measurements between labeled thiol functions of 
a2M and labeled proteases, it was suggested that 
the chymotrypsin binding sites of (YZM were pro- 
bably not too different whatever covalent or non- 
covalent binding was concerned. However, a 
Abbreviations: (YzM, uz-macroglobulin; FITC, fluores- 
cein isothiocyanate; IAEDns, N-(iodoacetylamino- 
ethyl)-5-naphthylamine-1-sulfonate 
Antithrombin Chymotrypsin 
definite answer could not be given, the two modes 
of binding occurring during the protease-azM 
complex formation as described for trypsin. 
Here, this hypothesis was reinvestigated by the 
same experimental approach, a simple method 
allowing to obtain specifically covalent or non- 
covalent binding of thrombin by cu2M. 
2. EXPERIMENTAL 
2.1. Materials 
Human a2M was prepared by Zn2+ affinity 
chromatography [9] from fresh plasma and was 
85% active as tested by trypsin binding [lo]. 
Thrombin was obtained as in [ 111, the enzyme 
showed a specific activity of 2500 NIH units/mg. 
Anti-thrombin III (AT III) was prepared by affini- 
ty chromatography using fraction IV as starting 
material and had a specific activity of 5.3 units/mg 
1111. 
2.2. Determination of enzymatic activities 
Protease activities were evaluated by the 
amidolytic activity monitoring on a Cary 118 C at 
37°C; the hydrolysis rates of chromogenic 
substrates at 405 nm were Sue-Alaz-Pro-Phe- 
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PNA from Bachem (USA) and H D Phe- 
Pip-Arg-pNA from Kabi Diagnostica (Sweden) 
being used for chymotrypsin and thrombin, 
respectively. In the presence of heparin, polybrene 
at a final concentration of 1 mg/ml was added to 
the reaction mixture according to the manufac- 
turer’s instructions. 
2.3. Labeling of proteases 
Chymotrypsin and thrombin were FITC-labeled 
as in [lo, 111. The extent of labeling was determin- 
ed from the ratio of the dye absorption at 495 nm 
(E = 66.8 mM_' . cm-‘) to that of the enzymes at 
280 nm (E = 45 and 61 mM_’ .cm-‘, respectively). 
2.4. Preparation of labeled and non-labeled 
protease-& complexes 
All complexes were prepared in 0.1 M NaCl, 
50 mM Tris-HCl (pH 7.5) and purified by 
Sephacryl S 200 filtration in this buffer. 
2.4.1. azM-Thrombin complexes 
Labeled or unlabeled thrombin was added to 
1 ,xM solution of c2M in the presence or absence of 
the specific SH reagent IAEDns [ 121 (final concen- 
tration 1 x 10V4 M). The reaction could be per- 
formed in the presence of 0.1 M hydroxylamine 
[ 131. The reaction mixtures were left 10 min at 
room temperature and the complexes were isolated 
as indicated. 
2.4.2. Chymotrypsin-cuzM-thrombin complexes 
This asymmetric complex was prepared in the 
same way: to 2.7 pM CYZM (in presence or absence 
of IAEDns) were first added 3 pM thrombin 
followed 1 min later by 3 PM chymotrypsin, the 
proteases being FITC-labeled or not. The extent of 
protease fixation was estimated using the indicated 
specific chromogenic substrates. 
2.5. Estimation of covalently bound thrombin 
Complexes of (YZM with FITC-labeled thrombin 
were dialyzed against 6 M guanidine chloride, 
0.5 M Tris-HCl (pH 8.0) buffer and filtered on 
Sephacryl S 300 in the same buffer. The extent of 
covalent binding of thrombin to CQM was 
estimated from the fluorescence peak area cor- 
responding to FITC-labeled thrombin co- 
migrating with high-iVr fragments of a2M. 
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2.6. Energy transfer measurements 
Transfer efficiencies were determined from the 
fluorescence quenching of IAEDns-azM by the 
bound FITC-labeled protease, by excitation at 
360 nm and emission at 470 nm. The average 
transfer efficiencies were given by the relation e = 
1 - Fr/F2, where Fr and F2 were the normalized 
fluorescence intensities of the donor (IAEDns) in 
the presence and in absence of the acceptor 
(FITC), respectively. A modified [lo] Farrand 
Mark I was used for fluorescence determinations. 
3. RESULTS AND DISCUSSION 
3.1. General characterization of the CUZM- 
thrombin complexes 
The free LY~M sulfhydryl groups which appeared 
upon thrombin-induced thioester cleavage, react 
with the specific -SH reagent IAEDns to an extent 
of 4 + 0.2 labels per CYZM molecule as estimated 
from the dye absorption at 335 nm of the isolated 
complex. On the other hand, the stoichiometry of 
the FITC-thrombin-ac2M complex is 0.92. Gel 
filtration of this complex under denaturing condi- 
tions shows that covalent binding of the protease 
occurs to an extent of 95 + 5%. The presence of 
2.3 FITC labels per thrombin molecule does not 
modify the rate of synthetic substrate hydrolysis 
but this rate is decreased to about 48% by linkage 
of the protease to CQM. 
The thrombin-cu2M stoichiometry is not greatly 
modified by the presence of hydroxylamine during 
the complex formation, it is found to be 0.80, but 
the u2M-binding of the protease becomes 95 + 5% 
non-covalent. In this complex, the thrombin activi- 
ty on the synthetic substrate is decreased to about 
58% with respect to the free enzyme. 
A 2000-fold molar excess of anti-thrombin III, 
with or without heparin, is unable to inhibit the ac- 
tivity of the complexed thrombin upon synthetic 
substrate, whatever the mode of binding, and even 
after 24 h of incubation at 37’C. These results 
show that complexed thrombin cannot react with 
its specific inhibitor and that non-covalently 
bound thrombin cannot be displaced as easily from 
its complex. The situation is therefore different 
from that observed with the cuzM-trypsin complex 
where inhibition [14] and displacement [ 151 of 
trypsin was observed after addition of soybean 
trypsin inhibitor. 
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Thrombin-cuzM-chymotrypsin complex can be 
easily obtained by sequential addition of thrombin 
and chymotrypsin to a2M. The extent of enzyme 
fixation may be determined by estimation of the 
activities of the proteases for their specific 
substrates, the rates of peptide hydrolysis being 
corrected for proteases-a2M binding (+ 12% and 
- 50% for chymotrypsin and thrombin, respec- 
tively). Under the experimental conditions already 
described, 1.05 & 0.1 thrombin and 0.9 f 0.1 
chymotrypsin molecules are bound per cv2M 
molecule. 
3.2. Energy transfer measurements 
Singlet-singlet energy transfer efficiencies were 
measured from fluorescence quenching of IAEDns 
labels bound to protease-induced thiol groups of 
cvzM by FITC-labeled proteases. Complexes of 
IAEDns-azM with unlabeled proteases and in- 
versely unlabeled c~2M with FITC proteases were 
also isolated and served as controls in absence of 
IAEDns to FITC transfer. In order to interpret the 
transfer efficiencies in terms of distance between 
donor and acceptor molecules, we use the model in 
1161; i.e., we assume: 
0) 
(ii) 
(iii) 
(iv) 
A random distribution of the labels on the 
chymotrypsin and thrombin surface, these en- 
zymes being considered as rigid spheres of a 
hydrous radius r = 20 and 23 A, respectively, 
as computed from molecular mass and partial 
specific volume (0.735 cm3/g) values; 
The probability of finding labels obeys a 
Poisson distribution; 
A mean value of the dipole-dipole orientation 
factor K2 = 0.67; 
A characteristic transfer distance between 
IAEDns and FITC R, = 44 A [ 171. 
The transfer efficiency value (table 1) determin- 
ed for the asymmetrical chymotrypsin-cuzM- 
thrombin complex is very close to that calculated 
for a single sphere transfer model; i.e., for an in- 
dividual protease surface labeled with both donor 
and acceptor molecules as previously described for 
the symmetrical chymotrypsin-cY2M-chymotryp- 
sin complex. The donor-labeled -SH groups of 
WY~M are in close contact with both chymotrypsin 
and thrombin surface. 
On the other hand, the e-value within the 
covalent thrombin-cY2M complex is significantly 
lower than that expected from the thrombin radius 
and the average labeling of the protease. This may 
result from the fact that energy transfer occurs 
within one a2M subunit, a cross transfer from 
donor molecules of one a2M subunit to acceptor 
molecules of the protease located on the other 
subunit being very unlikely despite the proximity 
of the two protease binding sites [lo]. 
Lastly, non-covalent binding of thrombin 
decreases the energy transfer efficiency to about 
15-20% indicating that the QzM-thrombin in- 
teraction is only slightly modified. This difference 
could be the consequence of a small displacement 
of the non-covalent bound thrombin molecule in 
its specific LYZM binding site as also suggested by 
the difference in the hydrolysis rate of the synthetic 
substrate. However, there is no drastic change in 
the environment of the bound enzyme. Covalently 
and non-covalently bound thrombin molecules are 
therefore located at identical sites in the 
&YzM-thrombin complex. This strengthens the view 
that covalent bonds do not contribute significantly 
to the protease-cuzM binding energy [ 181. 
It has been shown [13] that thrombin (even in ex- 
cess) cleaves only 2 chains of the cvzM molecule as 
has recently been reported for the plasmin cr2M in- 
Table 1 
Stoichiometry, average number of bound labels per a&l and CY&~ bound protease and 
energy transfer efficiencies, e, in different azM-protease complexes 
Complex IAEDns FITC e 
(wM) (protease) 
Chymotrypsin-cu*M-thrombin (1: 1: 1) 4 2.5 and 2.3 0.85 
Thrombin (covalent)-cu2M (1: 1) 4 2.3 0.65 
Thrombin (non-covalent)-cY2M (1: 1) 4 2.3 0.48 
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teraction [19]. However, all azM molecules are 
converted to the fast form by thrombin. The fast 
a2M-thrombin complex can react with 
chymotrypsin demonstrating the accessibility of 
the reaction sites. The remaining 2 chains are nor- 
mally cleaved. This observation is similar to the 
recently reported interaction of trypsin with the 
cuzM-plasmin complex [19]. Whereas the non- 
covalent thrombin-cu2M complex does not resist to 
denaturing aspects (SDS, guanidine), its stability in 
the presence of AT III and heparin is remarkable. 
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